首页> 美国卫生研究院文献>Molecules and Cells >Identification of Novel Subregions of LOH in Gastric Cancer and Analysis of the HIC1 and TOB1 Tumor Suppressor Genes in These Subregions
【2h】

Identification of Novel Subregions of LOH in Gastric Cancer and Analysis of the HIC1 and TOB1 Tumor Suppressor Genes in These Subregions

机译:胃癌LOH新亚区的鉴定以及这些亚区中HIC1和TOB1肿瘤抑制基因的分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Previously, we identified 3 overlapping regions showing loss of heterozygosity (LOH, R1-R3 from 11 to 30 cM) on chromosome 17 in 45 primary gastric cancers (GCs). The data indicated the presence of tumor suppressor genes (TSGs) on chromosome 17 involved in GC. Among the putative TSGs in these regions, HIC1 (in SR1) and TOB1 (in SR3) remain to be examined in GC. By immunohistochemistry (IHC), methylation-specific PCR (MSP) and western blot, we evaluated the expression and regulation status for HIC1 and TOB1 protein in GC. We narrowed down the deletion intervals on chromosome 17 and defined five smaller LOH subregions, SR1-SR5 (0.54 to 3.42 cM), in GC. We found that HIC1 had downregulated expression in 86% (91/106) and was methylated in 87% (26/30) of primary GCs. Of the primary GCs showing downregulation of HIC1 protein, 75% (18/24) had methylated HIC1 gene. TOB1 was either absent or expressed at reduced levels in 75% (73/97) of the GC samples. In addition, a general reduction was found in total and the ratio of unphosphorylated to phosphorylated TOB1 protein levels in the differentiated GC cell lines. Further analysis revealed significant simultaneous downregulation of both HIC1 and TOB1 protein in GC tissue microarray samples (67%, 52/78) and in primary GCs (65%, 11/17). These results indicate that silencing of HIC1 and TOB1 expression is a common occurrence in GC and may contribute to the development and progression of the disease.
机译:以前,我们在45个原发性胃癌(GC)中鉴定了17号染色​​体上3个重叠区域,显示杂合性缺失(LOH,R1-R3从11到30 cM)。数据表明与GC有关的染色体17上存在肿瘤抑制基因(TSG)。在这些区域的假定TSG中,HIC1(在SR1中)和TOB1(在SR3中)仍有待在GC中进行检查。通过免疫组化(IHC),甲基化特异性PCR(MSP)和蛋白质印迹,我们评估了GC中HIC1和TOB1蛋白的表达和调控状态。我们缩小了17号染色​​体的删除间隔,并在GC中定义了五个较小的LOH子区域SR1-SR5(0.54至3.42 cM)。我们发现,HIC1在86%(91/106)中下调了表达,​​并在87%(26/30)的主要GC中被甲基化。显示HIC1蛋白下调的主要GC中,有75%(18/24)具有甲基化的HIC1基因。 75%(73/97)的GC样品中不存在TOB1或以较低的水平表达。另外,在分化的GC细胞系中,总体上发现总体降低,未磷酸化的TOB1蛋白与磷酸化的TOB1蛋白水平之比降低。进一步的分析显示,GC组织微阵列样品(67%,52/78)和初级GC(65%,11/17)中的HIC1和TOB1蛋白同时显着下调。这些结果表明,HIC1和TOB1表达的沉默是GC中的常见现象,可能有助于疾病的发展和进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号